Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
No, BPC-157 isnt currently FDA-approved for therapeutic use
Researchers created segmental bone defects in rabbits, essentially removing a section of bone to create a gap that would not heal on its own
Once they came up with some promising candidates, they encountered another obstacle, which is the difficulty of getting peptides to enter cells
Higher doses increase peptide consumption and cost without guaranteed proportional benefit increases
US$ 22.44
US$ 23.85
US$ 27.24
